Research & Development

噜噜色色天使七七色与行星同名 吉利全新轿跑SUV正式定名星越


  “真的,他真的說過,徒兒可以作證!徒兒已經把這事告訴兩位師娘了!”   當年太祖高皇帝奪得天下之後,敘論戰功的時候,排在第一位的並非韓信,也不是張子房,而是留在漢中的蕭何。噜噜色   “可是……”色天使   “是一個男孩子!”   雲瑯曹襄看了許久,發現阿嬌好像是真的很開心,沒有憂傷的意思,就一起把目光盯在大長秋的臉上。七七色   雲瑯曹襄看了許久,發現阿嬌好像是真的很開心,沒有憂傷的意思,就一起把目光盯在大長秋的臉上。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo